↓ Skip to main content

Varenicline for smoking cessation: efficacy, safety, and treatment recommendations

Overview of attention for article published in Patient preference and adherence, September 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)

Mentioned by

news
2 news outlets
twitter
5 X users
patent
13 patents

Citations

dimensions_citation
55 Dimensions

Readers on

mendeley
107 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Varenicline for smoking cessation: efficacy, safety, and treatment recommendations
Published in
Patient preference and adherence, September 2010
DOI 10.2147/ppa.s10620
Pubmed ID
Authors

Jon O Ebbert, Kirk D Wyatt, J Taylor Hays, Eric W Klee, Richard D Hurt

Abstract

Smoking is the leading preventable cause of morbidity and mortality in the US, and decreasing smoking prevalence is a public health priority. Patients achieve the greatest success when quit attempts involve behavioral therapy combined with pharmacotherapy. Varenicline is the most recent addition to the pharmacotherapeutic armamentarium for the treatment of tobacco dependence. Varenicline is efficacious and cost-effective. Smoking relapse and adverse treatment-related side effects may decrease medication adherence and patient satisfaction with varenicline. In the clinical setting, varenicline treatment can be optimized by reducing doses in patients who experience intolerable side effects, increasing the dose in partial responders, and providing long-term maintenance therapy for relapse prevention.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 107 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 107 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 32 30%
Student > Master 18 17%
Researcher 9 8%
Student > Ph. D. Student 7 7%
Other 6 6%
Other 13 12%
Unknown 22 21%
Readers by discipline Count As %
Medicine and Dentistry 37 35%
Pharmacology, Toxicology and Pharmaceutical Science 14 13%
Psychology 7 7%
Nursing and Health Professions 4 4%
Chemistry 4 4%
Other 17 16%
Unknown 24 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 26. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 September 2020.
All research outputs
#1,492,679
of 25,374,647 outputs
Outputs from Patient preference and adherence
#59
of 1,757 outputs
Outputs of similar age
#4,828
of 103,828 outputs
Outputs of similar age from Patient preference and adherence
#1
of 3 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,757 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.5. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 103,828 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them